Neurofilaments degradation as an early molecular event in tri-ortho-cresyl phosphate (TOCP) induced delayed neuropathy

Toxicology

Volumn 258, Issue 2-3, 2009, Pages 94-100

  Song, Fuyong ^a   Yan, Yongjian ^b   Zhao, Xiulan ^a   Zhang, Cuili ^a   Xie, Keqin ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Neurofilament; Organophosphorus ester induced delayed neuropathy (OPIDN); Tibial nerve; Toxic axonopathy; Tri ortho cresyl phosphate (TOCP)

Indexed keywords

CALPAIN 1; NEUROFILAMENT H PROTEIN; NEUROFILAMENT L PROTEIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; TRI ORTHO CRESYL PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEN; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TIBIAL NERVE;

ADMINISTRATION, ORAL; ANIMALS; CHICKENS; FEMALE; KINETICS; NEUROFILAMENT PROTEINS; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVES; POLYNEUROPATHIES; TIBIAL NERVE; TRITOLYL PHOSPHATES;

ANIMALIA;

EID: 61349102382     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.01.011     Document Type: Article

References (36)

1. Abou-Donia M.B. Organophosphorus ester-induced delayed neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 21 (1981) 511-548
2. Abou-Donia M.B. The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chem. Biol. Interact. 87 (1993) 383-393
3. Abou-Donia M.B. Organophosphorus ester-induced chronic neurotoxicity. Arch. Environ. Health 58 (2003) 484-497
4. Abou-Donia M.B., and Graham D.G. Delayed neurotoxicity of O-ethyl-O-4-nitrophenyl phenylphosphonothioate: toxic effects of single oral dose on the nervous system of hens. Toxicol. Appl. Pharmacol. 48 (1979) 57-66
5. Abou-Donia M.B., and Lapadula D.M. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 405-440
6. Bischoff A. Ultrastructure of tri-ortho-cresyl phosphate poisoning in the chickens. II. Studies on spinal cord alterations. Acta Neuropathol. 15 (1970) 142-155
7. Bischoff A. The ultrastructure of tri-ortho-cresyl phosphate in poisoning. I. Studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropathol. 9 (1967) 158-174
8. Cavanagh J.B. Peripheral nerve changes in ortho-cresyl phosphate poisoning in the cat. J. Pathol. Bacteriol. 87 (1964) 365-383
9. Classen W., Gretener P., Rauch M., Weber E., and Krinke G.J. Susceptibility of various areas of the nervous system of hens to TOCP-induced delayed neuropathy. Neurotoxicology 17 (1996) 597-604
10. El-Fawal H.A., Jortner B.S., and Ehrich M. Use of the biventer cevicis nerve muscle preparation to detect early changes following exposure to organophosphates inducing delayed neuropathy. Fundam. Appl. Toxicol. 15 (1990) 108-120
11. El-Fawal H.A., Correll L., Gay L., and Ehrich M. Protease activity in brain, nerve, and muscle of hens given neuropathy-inducing organophosphates and a calcium channel blocker. Toxicol. Appl. Pharmacol. 103 (1990) 133-142
12. Grant P., and Pant H.C. Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 29 (2000) 843-872
13. Gupta R.P., Abdel-Rahman A., Jensen K.F., and Abou-Donia M.B. Altered expression of neurofilament subunits in diisopropyl phosphorofluoridate-treated hen spinal cord and their presence in axonal aggregations. Brain Res. 878 (2000) 32-47
14. Hisanaga S., and Hirokawa N. Dephosphorylation-induced interaction of neurofilaments with microtubules. J. Biol. Chem. 265 (1990) 21852-21858
15. Ishizaki Y., Tashiro T., and Kurokawa M. A calcium-activated protease which preferentially degrades the 160-kDa component of the neurofilament triplet. Eur. J. Biochem. 131 (1983) 41-45
16. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. Rev. Biochem. Toxicol. 4 (1982) 141-212
17. Johnson M.K. Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy (OPIDP) induced by some organophosphorus esters. Chem. Biol. Interact. 87 (1993) 339-346
18. Jortner B.S., and Ehrich M. Neuropathological effects of phenyl saligenin phosphate in chickens. Neurotoxicology 8 (1987) 303-314
19. Julien J.P. Neurofilament functions in health and disease. Curr. Opin. Neurobiol. 9 (1999) 554-560
20. Lee M.K., and Cleveland D.W. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr. Opin. Cell Biol. 6 (1994) 34-40
21. Lee M.K., Xu Z., Wong P.C., and Cleveland D.W. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122 (1993) 1337-1350
22. Lotti M. The pathogenesis of organophosphate neuropathy. Crit. Rev. Toxicol. 21 (1992) 465-487
23. Lotti M., and Moretto A. Organophosphate-induced delayed polyneuropathy. Toxicol. Rev. 24 (2005) 37-49
24. LoPachin R.M., He D., and Reid M.L. 2,5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve. Neurotoxicology 26 (2005) 229-240
25. Nixon R.A., Lewis S.E., and Marotta C.A. Posttranslational modification of neurofilament proteins by phosphate during axoplasmic transport in retinal ganglion cell neurons. J. Neurosci. 7 (1987) 1145-1158
26. Perrin B.J., and Huttenlocher A. Calpain. Int. J. Biochem. Cell Biol. 34 (2002) 722-725
27. Perrone C.C., Pernas-Alonso R., and Di Porzio U. Neurofilament homeostasis and motoneurone degeneration. BioEssays 23 (2001) 24-33
28. Petzold A., Gveric D., Groves M., Schmierer K., Grant D., Chapman M., Keir G., Cuzner L., and Thompson E.J. Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology. Exp. Neurol. 213 (2008) 326-335
29. Pope C.N., and Padilla S. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J. Toxicol. Environ. Health 31 4 (1990) 261-273
30. Schwarzschild M.A., Cole R.L., Meyers M.A., and Hyman S.E. Contrasting calcium dependencies of SAPK and ERK activations by glutamate in cultured striatal neurons. J. Neurochem. 72 (1999) 2248-2255
31. Shea T.B., Dahl D.C., Nixon R.A., and Fischer I. Triton-soluble phosphovariants of the heavy neurofilament subunit in developing and mature mouse central nervous system. J. Neurosci. Res. 48 (1997) 515-523
32. Suzuki K., Sorimachi H., Yoshizawa T., Kinbara K., and Ishiura S. Calpain: novel family members, activation, and physiologic function. Biol. Chem. Hoppe Seyler 376 (1995) 523-529
33. Tanaka D., and Bursian S.J. Degeneration patterns in the chicken central nervous system induced by ingestion of the organophosphorus delayed neurotoxin tri-ortho-tolyl phosphate-a silver impregnation study. Brain Res. 484 (1989) 240-256
34. Tsuda M., Tashiro T., and Komiya Y. Increased solubility of high molecular mass neurofilament subunit by suppression of dephosphorylation: its relation to axonal transport. J. Neurochem. 68 (1997) 2558-2565
35. Wagner O.I., Ascano J., Tokito M., Leterrier J.F., Janmey P.A., and Holzbaur E.L. The interaction of neurofilaments with the microtubule motor cytoplasmic dynein. Mol. Biol. Cell 15 (2004) 5092-5100
36. Zhao X.L., Zhu Z.P., Zhang T.L., Zhang C.L., Yu L.H., and Xie K.Q. Tri-ortho-cresyl phosphate (TOCP) decreases the levels of cytoskeletal proteins in hen sciatic nerve. Toxicol. Lett. 152 (2004) 139-147